Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 8.26
+0.03 (0.36%)
Jul 31, 2026, 3:04 PM CST
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 13.77 billion as of July 31, 2026. Its market cap has decreased by -18.20% in one year.
Market Cap
13.77B
Enterprise Value
12.30B
Revenue
2.56B
Ranking
n/a
PE Ratio
19.70
Stock Price
8.26
ChartMarket Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 13.77B, an increase of 227.35%. That is a compound annual growth rate of 7.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 13.77B | -13.75% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 15.92B |
| BrightGene Bio-Medical Technology | 14.34B |
| Jinyu Bio-technology | 13.81B |
| Mabwell (Shanghai) Bioscience | 12.28B |
| Inner Mongolia Furui Medical Science | 11.98B |
| Tibet Cheezheng Tibetan Medicine | 11.89B |
| InventisBio | 11.66B |
| HitGen | 11.06B |